Ucci-Brain-16-01- Feasibility Study Of Modified Atkins Ketogenic Diet In The Treatment Of Newly Diagnosed Malignant Glioma
Posted Date: May 15, 2019
- Investigator: Rekha Chaudhary
- Specialties: Cancer, Oncology
- Type of Study: Drug
The goal of this study is to assess the feasibility of inducing ketosis with MAD concurrent with radiation therapy by measuring serum beta-hydroxybuterate.
To Be Eligible: Patients Must Be 18+ Years Of Age And Have A High Grade Glioma (Brain Tumor). Life Expectancy >3 Months. No Other Uncontrolled Infection/Malignancy. Nonpregnant And Nonbreastfeeding.
Brain Cancer, Malignant Glioma, Glioma , Ucci-Brain-16-01
For More Information:
Uc Cancer Institute